Literature DB >> 2571449

Thermoregulatory responses of diabetic rats.

T H Shalaby1, M K Yousef, R K Dupré.   

Abstract

1. Thermal responses and skin microcirculation were measured in streptozotocin-induced diabetic (SD) rats during acute and chronic exposure to ambient (Ta) temperatures ranging from about 5 to 35 degrees C. 2. At 28 degrees C, SD rats had higher rate of oxygen consumptions (VO2), tail skin blood flow (SKBF), but lower rectal temperatures (Tre) than saline-injected controls. 3. Chronic exposure of the SD rats to 35 and 5 degrees C caused a sharp rise and decline in Tre, respectively. 4. At 35 degrees C, hyperthermia in the SD rats was associated with greater increase in VO2 than controls, but changes in SKBF were similar in both groups. 5. At 5 degrees C, VO2 changed similarly in both the SD and control rats, but vasoconstriction was greater in the controls. 6. The data suggest that hypothermia in SD rats may be associated with impairment of vasoconstriction and hyperthermia may be related to an increase VO2 not accompanied by greater vasodilation.

Entities:  

Mesh:

Year:  1989        PMID: 2571449     DOI: 10.1016/0300-9629(89)90800-1

Source DB:  PubMed          Journal:  Comp Biochem Physiol A Comp Physiol        ISSN: 0300-9629


  3 in total

1.  Mitochondrial superoxide and coenzyme Q in insulin-deficient rats: increased electron leak.

Authors:  Judith A Herlein; Brian D Fink; Dorlyne M Henry; Mark A Yorek; Lynn M Teesch; William I Sivitz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-21       Impact factor: 3.619

2.  Food restriction and streptozotocin differentially modify sensitivity to the hypothermic effects of direct- and indirect-acting serotonin receptor agonists in rats.

Authors:  Jun-Xu Li; Wouter Koek; Charles P France
Journal:  Eur J Pharmacol       Date:  2009-04-18       Impact factor: 4.432

Review 3.  Insulin dysfunction and Tau pathology.

Authors:  Noura B El Khoury; Maud Gratuze; Marie-Amélie Papon; Alexis Bretteville; Emmanuel Planel
Journal:  Front Cell Neurosci       Date:  2014-02-11       Impact factor: 5.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.